# Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-eculizumab-in-guillain-barre-syndrome-a-multicentre/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sonoko Misawa,Satoshi Kuwabara,Yasunori Sato,Nobuko Yamaguchi,Kengo Nagashima,K. Katayama,Yukari Sekiguchi,Yuta Iwai,Hiroshi Amino,Tomoki Suichi,Takanori Yokota,Yoichiro Nishida,Tadashi Kanouchi,Nobuo Kohara,Michi Kawamoto,Junko Ishii,Motoi Kuwahara,Hidekazu Suzuki,Koichi Hirata,Norito Kokubun,Ray Masuda,Juntaro Kaneko,Ichiro Yabe,Hidenao Sasaki,Kenichi Kaida,Hiroshi Takazaki,Norihiro Suzuki,Shigeaki Suzuki,Hiroyuki Nodera,Naoko Matsui,Shoji Tsuji,Haruki Koike,Ryo Yamasaki,Susumu Kusunoki,Sonoko Misawa,Satoshi Kuwabara,Yasunori Sato,Nobuko Yamaguchi,Kengo Nagashima,K. Katayama,Yukari Sekiguchi,Yuta Iwai,Hiroshi Amino,Tomoki Suichi,Takanori Yokota,Yoichiro Nishida,Tadashi Kanouchi,Nobuo Kohara,Michi Kawamoto,J. Ishii,Motoi Kuwahara,Hidekazu Suzuki,Koichi Hirata,Norito Kokubun,Ray Masuda,Juntaro Kaneko,Ichiro Yabe,Hidenao Sasaki,Kenichi Kaida,Hiroshi Takazaki,Norihiro Suzuki,Shigeaki Suzuki,Hiroyuki Nodera,Naoko Matsui,Shoji Tsuji,Haruki Koike,Ryo Yamasaki,Susumu Kusunoki,Takahide Nagashima,Toshio Shimizu,Makoto Hirotani,Michiyo Kadoya,Jin Nakahara,Junya Shimizu,Masahiko Tanaka,Gen Sobue,Masahisa Katsuno,Hideaki Yamaguchi,Hideyuki Ogata |
| Citations | 161 |
| DOI | 10.1016/s1474-4422(18)30114-5 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2799816764 |
| PMID | 29685815 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Hidekazu Suzuki](https://scholariq.org/researchers/hidekazu-suzuki/)
- [Koichi Hirata](https://scholariq.org/researchers/koichi-hirata/)

## Paper primary topic

- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)

## Paper topics

- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.